4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-012952
EVP, Research & CSO sold 1,375 shares at $30.00 ($41,250)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
- EVP, Research & CSO acquired 70,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2022-02-22 | Grant or award | +70,000 | 175,407 | D | ||
| Virgin Herbert EVP, Research & CSO | 2022-02-22 | Option exercise | +1,375 | $1.53 | $2,104 | 176,782 | D |
| Virgin Herbert EVP, Research & CSO | 2022-02-22 | Sale | −1,375 | $30.00 | $41,250 | 175,407 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2022-02-22 | Option exercise · Stock Option (Right to Buy) | −1,375 | 219,505 | D | ||
| Virgin Herbert EVP, Research & CSO | 2022-02-22 | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | D | ||
| Open-market sales · 1,375 sh · avg $30.00 · $41,250 | |||||||
Loading xslF345X03/doc4.xml…